Skip to main content
OpenTrials

Clinical trial condition

KRAS P.G12D

Explore clinical trials studying KRAS P.G12D. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

KRAS P.G12D trial results

Recruiting

A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.

NCT07456046

Conditions
KRAS P.G12D
Locations
  • D3 Bio Investigative Site 1402 San Antonio, Texas, United States
  • D3 Bio Investigative Site 1103 Randwick, New South Wales, Australia
  • D3 Bio Investigative Site 1201 Seoul, South Korea
  • D3 Bio Investigative Site 1203 Seoul, South Korea
View Trial Details